Status:
COMPLETED
Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis
Lead Sponsor:
Universidade Federal de Pernambuco
Conditions:
Endophthalmitis
Macula Edema
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The objective of this study is to evaluate the macular and choroidal thickness of patients submitted to intracameral moxifloxacin during the phacoemulsification surgery for endophthalmitis prophylaxis...
Detailed Description
Title: Evaluation and Comparison of Macular and Choroidal Thickness after Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis Purpose: The objective of this study is to evaluat...
Eligibility Criteria
Inclusion
- Any patients that will be submitted to phacoemulsification surgery in the Hospital de Clinicas of State University of Campinas (BRAZIL)
- Patients over 18 years old
- Patients who are able to perform SD-OCT
- Patients who sign the consent form
Exclusion
- Diabetic patients
- Patients with any macular changes prior to the surgery (epiretinal membranes, age macular disease, macular edema...)
- Patients who had any complication during phacoemulsification surgery
Key Trial Info
Start Date :
July 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2019
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03363295
Start Date
July 1 2017
End Date
December 30 2019
Last Update
November 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital das Clínicas da UNICAMP
Campinas, São Paulo, Brazil, 13083888